PATENT CLAIM ANALYSIS

Application Number: 16239531
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-12
Patent Classification: ["514", "449000"]

Abstract:
Disclosed herein are compositions and methods for treating kidney tumors by intratumoral injection administration of compositions comprising taxane particles such as docetaxel particles or paclitaxel particles.

Claim (Index 1):
A method of treating a kidney tumor in a subject, the method comprising administering an effective amount to treat the kidney tumor of a composition comprising docetaxel particles suspended in a liquid carrier to a kidney tumor of the subject via intratumoral injection, wherein the docetaxel particles comprise at least 98% docetaxel, wherein the docetaxel particles have a mean particle size (number) of from 0.1 microns to 5 microns, and wherein the docetaxel particles have a specific surface area (SSA) of at least 35 m 2 /g.

Metadata:
- Claim Count in Document: 80.0
- Percentile: 99.0
- Lexical Diversity: 1.125
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['16007095', '16136502', '15895197', '15174505', '12872156']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7138958952752305
- 35 USC 102 Novelty (BERT): 0.5251700658027972
- Combined Prediction Score: 0.6950233123279871
- Mean Citation Score: 213.92878
- Max Citation Score: 248.25058
- Similarity Product: 153.07688034895898

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test